top of page
![](https://static.wixstatic.com/media/c93e62_641b6540fbfe4ae2bd10d2437e557eb4~mv2.jpg/v1/fill/w_288,h_262,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/c93e62_641b6540fbfe4ae2bd10d2437e557eb4~mv2.jpg)
![scientific-chemistry-glassware-for-research-in-lab-2021-09-03-13-36-50-utc.jpg](https://static.wixstatic.com/media/c93e62_7339fa32923d4680aa78c38c8dfc0bb5~mv2.jpg/v1/fill/w_147,h_98,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/c93e62_7339fa32923d4680aa78c38c8dfc0bb5~mv2.jpg)
ACESION PHARMA
A Danish biotech aiming to develop more efficacious & safer drugs for the treatment of atrial fibrillation
ABOUT
ACESION
Acesion Pharma ApS is a Danish biotech company founded in 2011 as a spin out from the company Neurosearch and University of Copenhagen. By inhibiting the SK ion channel, we aim to develop first-in-class drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
![biotechnology-research-scientist-viewing-specimen-2022-03-08-00-59-52-utc.jpg](https://static.wixstatic.com/media/c93e62_66bde65c5c7d462ea1c7f6eea3be127a~mv2.jpg/v1/fill/w_593,h_445,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/biotechnology-research-scientist-viewing-specimen-2022-03-08-00-59-52-utc.jpg)
bottom of page